ADAM2 and cancer: In addition, inhibiting ADAM2 surface expression or treatment with ADAM2 blocking antibodies (alone or in combination with immune-checkpoint inhibitors) might represent a therapeutic avenues for a substantial proportion of cancer patients whose tumors have aberrant ADAM2 expression to reinvigorate their endogenous immune responses to combat their cancers.